16596262|t|Polymorphism in ABCA1 influences CSF 24S-hydroxycholesterol levels but is not a major risk factor of Alzheimer's disease.
16596262|a|The ATP-binding cassette transporter A1 (ABCA1) mediates reverse cholesterol transport, polymorphisms have been shown to influence the levels of cholesterol and of HDL and the risk of coronary artery disease. Since altered cholesterol metabolism is also involved in Alzheimer's disease (AD), the effects of two ABCA1 polymorphisms (G-395C promoter polymorphism (rs 2246293) and exonic R219K) on the risk of AD in 241 AD patients and 294 non-demented controls, and on CSF cholesterol and 24S-hydroxycholesterol in 74 AD patients and 42 non-demented controls were investigated. None of the investigated ABCA1 polymorphisms influenced the risk of AD. However, the ABCA1 G-395C polymorphism influenced CSF levels of 24S-hydroxycholesterol, but not of cholesterol, whereas the R219K influenced neither CSF levels of 24S-hydroxycholesterol nor cholesterol. Our data support the observation that ABCA1 polymorphisms influence cholesterol metabolism of the brain, but might not act as a major risk factor in AD.
16596262	16	21	ABCA1	Gene	19
16596262	37	59	24S-hydroxycholesterol	Chemical	MESH:C044563
16596262	101	120	Alzheimer's disease	Disease	MESH:D000544
16596262	126	161	ATP-binding cassette transporter A1	Gene	19
16596262	163	168	ABCA1	Gene	19
16596262	187	198	cholesterol	Chemical	MESH:D002784
16596262	267	278	cholesterol	Chemical	MESH:D002784
16596262	306	329	coronary artery disease	Disease	MESH:D003324
16596262	345	356	cholesterol	Chemical	MESH:D002784
16596262	388	407	Alzheimer's disease	Disease	MESH:D000544
16596262	409	411	AD	Disease	MESH:D000544
16596262	433	438	ABCA1	Gene	19
16596262	454	460	G-395C	DNAMutation	tmVar:c|SUB|G|-395|C;HGVS:c.-395G>C;VariantGroup:2;CorrespondingGene:19;CorrespondingSpecies:9606
16596262	484	494	rs 2246293	SNP	tmVar:rs2246293;VariantGroup:0;CorrespondingGene:19;RS#:2246293;CorrespondingSpecies:9606
16596262	507	512	R219K	ProteinMutation	tmVar:p|SUB|R|219|K;HGVS:p.R219K;VariantGroup:1;CorrespondingGene:19;RS#:2230806;CorrespondingSpecies:9606;CA#:120495
16596262	529	531	AD	Disease	MESH:D000544
16596262	539	541	AD	Disease	MESH:D000544
16596262	542	550	patients	Species	9606
16596262	593	604	cholesterol	Chemical	MESH:D002784
16596262	609	631	24S-hydroxycholesterol	Chemical	MESH:C044563
16596262	638	640	AD	Disease	MESH:D000544
16596262	641	649	patients	Species	9606
16596262	723	728	ABCA1	Gene	19
16596262	766	768	AD	Disease	MESH:D000544
16596262	783	788	ABCA1	Gene	19
16596262	789	795	G-395C	DNAMutation	tmVar:c|SUB|G|-395|C;HGVS:c.-395G>C;VariantGroup:2;CorrespondingGene:19;CorrespondingSpecies:9606
16596262	834	856	24S-hydroxycholesterol	Chemical	MESH:C044563
16596262	869	880	cholesterol	Chemical	MESH:D002784
16596262	894	899	R219K	ProteinMutation	tmVar:p|SUB|R|219|K;HGVS:p.R219K;VariantGroup:1;CorrespondingGene:19;RS#:2230806;CorrespondingSpecies:9606;CA#:120495
16596262	933	955	24S-hydroxycholesterol	Chemical	MESH:C044563
16596262	960	971	cholesterol	Chemical	MESH:D002784
16596262	1011	1016	ABCA1	Gene	19
16596262	1041	1052	cholesterol	Chemical	MESH:D002784
16596262	1122	1124	AD	Disease	MESH:D000544
16596262	Association	MESH:D003324	19
16596262	Association	MESH:D002784	19
16596262	Association	MESH:D002784	MESH:D000544
16596262	Association	MESH:C044563	HGVS:c.-395G>C;CorrespondingGene:19
16596262	Association	MESH:C044563	19

